Literature DB >> 18617892

SUMO1 modification of NF-kappaB2/p100 is essential for stimuli-induced p100 phosphorylation and processing.

Jaya Vatsyayan1, Guoliang Qing, Gutian Xiao, Jing Hu.   

Abstract

A primary step in activating the alternative nuclear factor-kappaB (NF-kappaB) pathway requires NF-kappaB2/p100 processing to generate p52. In most cases, stimuli-induced p100 processing is dependent on NF-kappaB-inducing kinase/IkappaB kinase alpha-mediated phosphorylation and ubiquitination. Here, we report that post-translational modification of p100 at specific sites by the small ubiquitin-like modifier (SUMO) is another determining factor for stimuli-induced p100 processing. The results show that basal SUMO modification is required for stimuli-induced p100 phosphorylation and that blocking SUMOylation of p100, either by site-directed mutation or by short interfering RNA-targeted diminution of E2 SUMO-conjugating enzyme Ubc9, inhibits various physiological stimuli-induced p100 processing and ultimate activation of the alternative NF-kappaB pathway. Together, these findings show the crucial role of SUMO1 modification in p100 processing and provide mechanistic insights into the participation of SUMO1 modification in the regulation of signal transduction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18617892      PMCID: PMC2529344          DOI: 10.1038/embor.2008.122

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  24 in total

1.  Insufficient p65 phosphorylation at S536 specifically contributes to the lack of NF-kappaB activation and transformation in resistant JB6 cells.

Authors:  Jing Hu; Hiroyasu Nakano; Hiroaki Sakurai; Nancy H Colburn
Journal:  Carcinogenesis       Date:  2004-06-10       Impact factor: 4.944

2.  Ubc9p is the conjugating enzyme for the ubiquitin-like protein Smt3p.

Authors:  E S Johnson; G Blobel
Journal:  J Biol Chem       Date:  1997-10-24       Impact factor: 5.157

Review 3.  SUMO: a history of modification.

Authors:  Ronald T Hay
Journal:  Mol Cell       Date:  2005-04-01       Impact factor: 17.970

4.  Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli.

Authors:  Zhao-Hui Wu; Yuling Shi; Randal S Tibbetts; Shigeki Miyamoto
Journal:  Science       Date:  2006-02-24       Impact factor: 47.728

5.  beta-TrCP binding and processing of NF-kappaB2/p100 involve its phosphorylation at serines 866 and 870.

Authors:  Chunyang Liang; Minying Zhang; Shao-Cong Sun
Journal:  Cell Signal       Date:  2005-11-21       Impact factor: 4.315

6.  SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation.

Authors:  J M Desterro; M S Rodriguez; R T Hay
Journal:  Mol Cell       Date:  1998-08       Impact factor: 17.970

7.  CD40 regulates the processing of NF-kappaB2 p100 to p52.

Authors:  H J Coope; P G P Atkinson; B Huhse; M Belich; J Janzen; M J Holman; G G B Klaus; L H Johnston; S C Ley
Journal:  EMBO J       Date:  2002-10-15       Impact factor: 11.598

8.  Preferential interaction of sentrin with a ubiquitin-conjugating enzyme, Ubc9.

Authors:  L Gong; T Kamitani; K Fujise; L S Caskey; E T Yeh
Journal:  J Biol Chem       Date:  1997-11-07       Impact factor: 5.157

9.  Induction of p100 processing by NF-kappaB-inducing kinase involves docking IkappaB kinase alpha (IKKalpha) to p100 and IKKalpha-mediated phosphorylation.

Authors:  Gutian Xiao; Abraham Fong; Shao-Cong Sun
Journal:  J Biol Chem       Date:  2004-05-11       Impact factor: 5.157

10.  Transcription factor Sp3 is silenced through SUMO modification by PIAS1.

Authors:  Alexandra Sapetschnig; Grigore Rischitor; Harald Braun; Andreas Doll; Marion Schergaut; Frauke Melchior; Guntram Suske
Journal:  EMBO J       Date:  2002-10-01       Impact factor: 11.598

View more
  26 in total

1.  Expanding NFκB and SUMO ties.

Authors:  Moon-Hee Lee; Shigeki Miyamoto
Journal:  Cell Cycle       Date:  2011-12-01       Impact factor: 4.534

Review 2.  NF-κB addiction and its role in cancer: 'one size does not fit all'.

Authors:  M M Chaturvedi; B Sung; V R Yadav; R Kannappan; B B Aggarwal
Journal:  Oncogene       Date:  2010-12-20       Impact factor: 9.867

Review 3.  Nuclear initiated NF-κB signaling: NEMO and ATM take center stage.

Authors:  Shigeki Miyamoto
Journal:  Cell Res       Date:  2010-12-28       Impact factor: 25.617

Review 4.  Specification of DNA binding activity of NF-kappaB proteins.

Authors:  Fengyi Wan; Michael J Lenardo
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-10       Impact factor: 10.005

Review 5.  Multifaceted roles of TRIM38 in innate immune and inflammatory responses.

Authors:  Ming-Ming Hu; Hong-Bing Shu
Journal:  Cell Mol Immunol       Date:  2017-02-13       Impact factor: 11.530

6.  Induction of Gsk3β-β-TrCP interaction is required for late phase stabilization of β-catenin in canonical Wnt signaling.

Authors:  Chenxi Gao; Guangming Chen; Guillermo Romero; Stergios Moschos; Xiang Xu; Jing Hu
Journal:  J Biol Chem       Date:  2014-01-22       Impact factor: 5.157

7.  SUMO conjugation regulates immune signalling.

Authors:  Sushmitha Hegde; Amarendranath Soory; Bhagyashree Kaduskar; Girish S Ratnaparkhi
Journal:  Fly (Austin)       Date:  2020-08-31       Impact factor: 2.160

8.  HDAC2 promotes eIF4E sumoylation and activates mRNA translation gene specifically.

Authors:  Xiang Xu; Jaya Vatsyayan; Chenxi Gao; Christopher J Bakkenist; Jing Hu
Journal:  J Biol Chem       Date:  2010-04-26       Impact factor: 5.157

Review 9.  Kinase-SUMO networks in diabetes-mediated cardiovascular disease.

Authors:  Eugene Chang; Jun-Ichi Abe
Journal:  Metabolism       Date:  2016-01-16       Impact factor: 8.694

Review 10.  Non-canonical NF-κB signaling pathway.

Authors:  Shao-Cong Sun
Journal:  Cell Res       Date:  2010-12-21       Impact factor: 25.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.